Solid YoY growth masked by QoQ weakness and near-term guidance misses
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 5/10
Grade C
Loan growth 24% (vs 25% guide), ROA 1.09% (vs ~1.5%), NIM 3.66% (vs 3.75–4.0%), ROE 12.71% (vs 15%); acknowledged but framed as temporary.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
CSB delivered solid YoY growth (+23.7% revenue, +26.5% PAT) but misses key near-term guidance: ROA 1.09% vs 1.5%, NIM 3.66% vs 3.75–4.0%, ROE 12.71% vs 15%, and sharp QoQ PAT decline of -25.6%. Deposit funding cost (6.5%) and bulk-deposit dependency (52% of total) compress margins while retail franchise won't scale until FY28. Long-term SBS 2030 vision is credible, but near-term margin and ROA recovery uncertain.
₹1287.3 Cr
Revenue · +23.7% YoY₹150 Cr
Reported PAT · +26.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
PAT growth 27% YoY
OVERSTATEDDelivered 26.5% YoY growth (₹150 Cr vs ₹118.7 Cr Q1 FY26)
Advance growth 24% YoY, guidance 25%
MissedDelivered 24% YoY vs prior 25% guidance
NIM at 3.66% sustained, stable guidance
MISSNIM 3.66% below prior range of 3.75–4.0%; below guidance
ROA 1.09% vs target 1.5%
MISSDelivered 1.09%, well below prior guidance of ~1.5%, acknowledged shortfall
ROE 12.71%, target Lakshman Rekha 15%
MISSDelivered 12.71% vs 15% target; below guidance
Q1 is worst-case scenario for NIM
METNIM 3.66% Q1 FY27 vs 3.54% Q1 FY26; narrative supported but doesn't guarantee recovery
PAT down QoQ, due to seasonal/regulatory factors
OVERSTATEDQoQ PAT -25.6% is sharp; seasonality invoked but severity suggests execution challenge
Earnings quality
What changed since the last call
NIM guidance repositioned lower end
DowngradePrior guidance 3.75–4.0%, now management guiding 'around 3.75%'. Q1 delivered 3.66%, below range. Downgrade reflects deposit cost pressure from bulk funding (52% of mix).
ROA guidance floor clarified to 1.3%
DowngradePrior: 'around 1.5%'. Now: '1.3–1.5% with 1.5% internal target but will not go below 1.3%'. Q1 delivered 1.09%, below even the new floor. Implies management is hedging.
Retail franchise launch delayed to FY28
DowngradeCASA and retail deposits to scale from FY28, not earlier. Leaves 3–4 quarters of bulk-funded growth, margin compression persists until then. No acceleration announced.
Gold portfolio mix path remains intact but articulated
NeutralGold 54%→50% this year, 30% by 2030. No change to prior guidance, but clarified it will take time as wholesale/SME grow. Runoff of ₹2,100 Cr repledger portfolio shows proactive deleveraging.
The Q&A
Moderate to high. Vibhor Talreja (6-year shareholder) pressed on retail assets not growing despite investments, technology delays, and low visible near-term uplift vs expectations. Parag Jariwala challenged wholesale funding strategy (wholesale liabilities costly, assets low-margin). Puneet Balani drilled into NIM drivers and deposit mix volatility. Management responded with detailed operational explanations but defensive tone; acknowledged 'worst-case scenario' Q1 but did not commit to recovery timeline. Analysts were skeptical but not combative.
Gold portfolio regulation impact — Puneet Balani, Dolat Capital
AnsweredGold regulated but manageable; glide path to 30% by 2030 via other business growth. Bulk deposits intentional to fund advance growth while retail franchise built from FY28. Cost of funds 6.5%, acceptable given LCR 123%.
Wholesale funding, margin trade-off — Parag Jariwala, White Oak
PartialNIM guidance 3.75% intact for FY. Wholesale building transaction banking (liability growth, non-funded income). Cost of funds in line with retail, showing franchise, not tactical. ROA/RAROC targets to be met long-term as gold mix reduces.
Asset quality volatility — Parag Jariwala, White Oak
PartialVolatility in BLG/SME (small portfolio); slippages in Q1 ₹98 Cr lower than Q3. Not in wholesale. Well-collateralized, recoveries expected Q2/Q3. Raised SME credit bar due to tariff/supply-chain uncertainty.
Other income decline — Saumil Shah, Paras Investments
AnsweredTreasury conservative, not booking small profits (held AFS book for future). Insurance reduced proactively due to compliance focus (topped CPGRAMS list). Processing fees down due to gold disbursement cutback (regulatory implementation, lack of price appreciation).
ROA/ROE guidance revision — Saumil Shah, Paras Investments
DodgedNo formal revision. Internal target 1.5%, but responding to question: will not go below 1.3% this year. Q1 lower due to seasonality, will make up in year (same as last year trajectory).
Promoter IDBI deal impact — Saumil Shah, Paras Investments
DodgedCSB never had conversations on this. Fairfax said 'continue business as usual, nothing changes.' CSB management runs bank independently (e.g., chose Oracle tech autonomously).
Retail franchise credibility — Vibhor Talreja, Nest Amplifier
PartialSBS 2030 is strategic vision spanning 8 years. Built 5 pillars (governance, compliance, human capital—strong; technology delayed but now done). Scale phase FY27–30. Tactical vs strategic play: executing quarter-on-quarter while building long-term. Execution now firmly on track.
Growth guidance (wholesale, gold) — Puneet Balani, Dolat Capital
AnsweredWholesale 35–40% YoY, gold 30–35% YoY. To move gold from 54% to 50% mix, other businesses must outgrow gold.
Unsecured retail expansion — J Manivasagam, Individual Investor
Answered2% intentional; cycle not fully over, jobs/AI disruption concerns. Will focus from FY28 onwards when retail liability franchise in place. Risk-averse for now.
Disbursement collapse — J Manivasagam, Individual Investor
AnsweredGold disbursements down due to ₹2,100 Cr repledger runoff (RBI guidance to discontinue), regulatory end-use monitoring implementation, lack of gold price appreciation (customers not re-leveraging). Wholesale disbursements up. Technical, not portfolio decline.
Guidance
Loan growth (wholesale 35–40%, gold 30–35%)
MediumFY27 advance guidance, underpinned by deposit growth and liquidity (LCR 123%). Gold growth dependent on price cycle and regulatory environment.
NIM around 3.75% for FY27
MediumPrior range 3.75–4.0%; now targeting lower end. Q1 3.66% below. Recovery expected as bulk deposit repricing, CD rates normalize, FCNR inflows anticipated. Retail franchise from FY28 to reduce cost of funds.
ROA 1.3–1.5% (internal target 1.5%)
LowQ1 delivered 1.09%, well below floor. Management says 'will not go below 1.3%' but offers no specific path. Dependent on leverage from deposits, cost control, and credit cycle stability.
ROE target 15% (Lakshman Rekha)
LowQ1 12.71%; management says 'will try to touch' if execution right, suggesting 15% is aspirational, not committed.
Technology capex complete; no major additional capex disclosed
HighTech transformation completed post-delays. Ongoing: retail sales machinery rollout, branch expansion (already 868), transaction banking capabilities.
Risks the call surfaced
Deposit cost pressure
HighBulk deposits 52% of total, 40% of deposits; cost of funds 6.5% vs lower retail rates. NIM compressed to 3.66% from guidance range 3.75–4.0%. Retail franchise (CASA, savings) not launching until FY28, leaving 3+ quarters of headwind.
Asset quality volatility (BLG/SME)
MediumSlippages volatile (₹98 Cr Q1, ₹200 Cr Q3, ₹60 Cr Q4); small portfolio base magnifies swings. BLG/SME yielding lower (9.25%) due to raised credit bar (tariff, supply-chain risks). Recoveries expected but uncertain timing.
Gold loan regulation
MediumGold 54% of portfolio; yield 11.85%, but disbursements suppressed due to regulatory end-use monitoring implementation this quarter. LTV 75% vs peers 65%; higher risk if cycle turns. Agri gold (subset) at 85% LTV; Board guidance to reduce this mix.
ROA/ROE below guidance
MediumROA 1.09% vs guidance 1.5% (41 bp miss); ROE 12.71% vs 15% (229 bp miss). Q1 acknowledged as 'worst case' but no specific recovery catalyst. Guidance softened to 1.3–1.5% ROA floor, suggesting confidence eroding.
Retail franchise execution risk
MediumRetail assets have not grown materially over 6 years; retail liabilities not launching until FY28. Technology delayed 2.5 years, now claimed 'on track.' CASA/savings products 'being built,' sales team 'being put in place'—launch not imminent. Shareholder skepticism high (Vibhor Talreja pressed on 6-year lack of visible progress).
QoQ PAT decline sharpness
MediumPAT fell from ₹202 Cr (Q4 FY26) to ₹150 Cr (Q1 FY27), a -25.6% QoQ decline. Management attributes to seasonality and deposit cost flow-through from prior quarter, but magnitude suggests execution challenge or one-time items not fully disclosed.
Wholesale franchise profitability uncertainty
LowWholesale growing 35–40% YoY but not yet meeting ROA/RAROC targets. Transaction banking investments ongoing; franchise still in build phase. Cost of funds for wholesale almost in line with retail, showing no economics advantage yet.
Management
Score 6/10. Clear on long-term strategy (SBS 2030) and operational details; defensive tone when pressed on near-term execution gaps. Declined to discuss IDBI/Fairfax deal, framing it as promoter matter. Transparent on challenges (NIM, AQ, disbursement) but heavy use of 'worst case' and 'temporary' framings to soften misses. Acknowledged ROA/NIM/ROE shortfalls vs guidance. Loan growth 24% vs 25% (missed 1 pp). Technology delayed 2.5 years but now on track. Retail assets not growing meaningfully after 6 years. Deposits outperformed (26% vs ~25% guidance). Track record: mixed quarter-to-quarter, but annual targets largely met historically.
1 · Q2 FY27
Deposit cost stabilization, NIM recovery; SME slippages upgrade; retail sales machinery ramp
2 · H2 FY27
Gold price cycle, disbursement recovery if prices rise; insurance/processing fee pickup
3 · FY28 onwards
CASA and retail deposits launch, franchise scaling expected to drive margins, ROA/ROE recovery
Long-term SBS 2030 vision is credible, but near-term margin and ROA recovery uncertain.
CSB Bank Q1: net profit up 27% YoY to ₹150 Cr, but slips 26% QoQ as provisions rise
PAT +26.51% YoY · revenue +23.67% · margins compressing
₹1,287.32 Cr
+23.67% YoY
₹150.04 Cr
+26.51% YoY
9.9%
+0.7pp YoY
₹8.65
CSB Bank's Q1 FY27 (standalone; the bank has no subsidiaries, so no consolidated statement exists) delivered net profit of ₹150.04 Cr, up 26.5% YoY from ₹118.60 Cr, on total income of ₹1,516.07 Cr (+18% YoY) and net interest income of ₹478.66 Cr (+26% YoY). The year-on-year print is strong and clean — profit grew faster than the 23.7% rise in interest income, and there are no exceptional or extraordinary items on either side. Sequentially, though, profit fell 25.6% from Q4 FY26's ₹201.58 Cr, so the quarter reads as strong YoY growth alongside a normalisation off a seasonally elevated fourth quarter.
Q1 FY-2027 vs prior quarters
Two lines explain the sequential drop. Provisions (ex-tax) more than doubled to ₹49.03 Cr from ₹23.02 Cr in Q4 (still below the ₹60.79 Cr booked a year ago), and other income slipped to ₹228.75 Cr from a seasonally strong ₹306.21 Cr in Q4, where treasury and PSLC gains typically peak. Operating profit at ₹250.77 Cr was up 13.8% YoY but down 14.6% QoQ. Annualised ROA fell to 1.06% from 1.50% in Q4 FY26, running below management's ~1.5% full-year guide; core operating margin (OPM) eased to 19.5% from 21.2% a year earlier, even as reported net margin edged up to 9.9% from 9.2% YoY. So the profitability guideposts (ROA, OPM) compressed while headline net margin held.
The stock went into the print at ₹347.35, down 4.5% over the past month of trading.
For context: revenue is at a 6-quarter high.
Management is targeting loan growth around 25% for the upcoming year, contingent on the successful build-out of its deposit franchise. They expect to sustain key profitability metrics with an ROA around 1.5% and ROE of 15%, while Net Interest Margins (NIM) are guided to remain in a stable range of 3.75% to 4.0%. The st
— This quarter: missed
Growth, by contrast, is tracking the ~25% loan-and-deposit ambition management laid out on the last call: the pre-result business update showed deposits up 26% YoY to ₹45,415 Cr and gross advances up 24% to ₹40,866 Cr, with the gold loan book up 47% to ₹21,906 Cr. Asset quality held firm — Gross NPA 1.75% (₹715.42 Cr), Net NPA 0.39%, CAR 19.96%. No brokerage consensus is published for this mid-cap, and the bank issued no separate result press release, so the net read is: franchise expansion on target and YoY earnings momentum intact, but profitability running below the guided run-rate as provisioning normalises off Q4 lows. Alongside the results, the board approved a new ESOS 2026 scheme and granted 61,565 options at ₹370.
W1
Provision run-rate: whether Q1's ₹49.03 Cr normalises or climbs; it doubled QoQ and drove the sequential PAT dip
W2
ROA trajectory back toward the guided ~1.5% (Q1 at 1.06%) and NIM holding in the guided 3.75–4.0% band
W3
Whether the 24–26% deposit/advance growth sustains the ~25% loan-growth target through FY27
Bank format, source in ₹ Lakhs (÷100 to Cr). revenueFromOperations = Interest earned ₹1,287.32 Cr (matches our 'revenue' convention for this bank); totalExpenses = Total Expenditure ₹1,265.30 Cr + Provisions ex-tax ₹49.03 Cr = ₹1,314.33 Cr, so TotalIncome − totalExpenses = PBT ₹201.74 Cr. No exceptional/extraordinary items either side. Standalone only — bank has no subsidiaries/associates (note 11), so consolidated is N/A, not missing. Clean, legible digital PDF.
The 26.5% PAT Growth That Doesn't Redeem the Guidance Shortfalls
Year-on-year profit jumped solidly, but loan growth, margins, and ROA all missed guidance. The quarter is worse than the headline suggests—and the market is pricing it that way.
+26.5%
₹150 Cr vs ₹118.7 Cr Q1 FY26
-25.6%
₹202 Cr Q4 → ₹150 Cr Q1
1.09%
vs 1.5% target, -41 bp
3.66%
vs 3.75–4.0% range, -9 bp
CSB Bank delivered headline growth that looks solid—revenue up 23.7%, PAT up 26.5% year-on-year. But step back. Loan growth came in at 24%, missing the 25% guidance by 100 basis points. ROA slumped to 1.09%, missing the 1.5% target by 41 basis points. Net Interest Margins compressed to 3.66%, below the guided range of 3.75–4.0%. And sequentially, profit collapsed 25.6%, dragging from ₹202 crore in Q4 to ₹150 crore here. This is not a quarter the bank's prior guidance anticipated.
The deposit cost trap
The core problem is structural, not seasonal. CSB's deposit funding is 52% bulk deposits at a cost of funds of 6.5%—expensive, locked in, and squeezing NIM at a time when the bank hasn't yet built its retail franchise (CASA at 19.41%, scheduled to scale only from FY28 onwards). Other income collapsed 7% year-on-year: treasury gains halved from ₹53 crore to ₹3 crore, insurance income cut back due to compliance focus, and processing fees suppressed because gold disbursements fell sharply due to regulatory end-use monitoring implementation. Management frames this as a 'worst-case scenario' for NIM and promises recovery, but the timing is vague, and the recovery path—dependent on deposit mix, rate environment, and retail launch execution—is uncertain.
Funding or liquidity is not a problem for us; LCR is 123%. Taking it further up with this kind of cost of funds is inefficient for the bank.
Claims vs. what holds up
What changed on this call vs. prior guidance
NIM guidance repositioned to lower end: now 'around 3.75%' vs prior 3.75–4.0% range
ROA floor clarified to 1.3–1.5% (vs prior 'around 1.5%'); management says 'will not go below 1.3%' but offers no recovery path
Retail deposits and CASA launch pushed to FY28 (no acceleration announced); leaves 3+ quarters of bulk-funded margin compression
Gold portfolio glide path to 30% by 2030 reaffirmed, but no new drivers announced
Where the bull-and-bear case stand
Advances +24% YoY, deposits +26% YoY—both outpacing industry
Asset quality stable: NNPA 0.39%, high PCR 77.96%, strong capital (CRAR 19.96%)
Technology transformation complete; core banking and transaction systems live
SBS 2030 strategy quantified and achievable: gold mix reduction underway, wholesale scaled to 26% of book
Reported profit leans on YoY growth, but QoQ collapse -25.6% signals underlying weakness
Deposit cost 6.5%, 52% bulk mix—expensive funding until retail franchise scales FY28
ROA 1.09%, NIM 3.66%, ROE 12.71% all miss guidance; recovery path and timeline vague
Retail assets immaterial after 6 years; franchise launch pushed to FY28; no visible near-term profit lever
Other income collapsed -7% YoY; treasury gains down 94% (₹53 Cr→₹3 Cr)
Asset quality volatile in SME/BLG; slippages ₹98 Cr Q1 (was ₹200 Cr Q3); recoveries uncertain
The market's verdict
The stock closed the day before results at ₹343.2. On day 1 post-result, it fell 1.47%; by day 3, it was down 1.73%; by day 5, it had fallen 2.83%. The weakness did not fade—it persisted. At ₹329.9, the stock now trades 42.57% below its all-time high of ₹574.4, below its 20-day, 50-day, and 200-day moving averages (₹350.25, ₹354.54, ₹393.84 respectively). RSI at 32.2 signals oversold but not yet capitulation. FII ownership fell from 14.16% in Q3 FY26 to 12.84% in Q4 FY26, a 132-basis-point outflow in the most recent quarter; DII ownership also trimmed slightly (15.63% → 15.22%). Promoter stake stable at 40%. The market is not buying the turnaround narrative; it is pricing uncertainty and near-term margin headwind.
Risks, ranked by how much they should concern a holder
Deposit cost persistence: bulk 52%, cost 6.5%, retail not scaling until FY28
HighNIM compression of 9 bp below guidance is not a quarterly event—it is structural until retail franchise launches. That's 3+ quarters of margin pressure. Recovery is dependent on deposit mix shift and retail CASA/deposits not yet in place.
ROA/profitability recovery uncertain: Q1 1.09% vs 1.5% target, path vague
HighManagement softened guidance to '1.3–1.5%' and says 'will not go below 1.3%,' but offered no specific actions or timeline. If ROA doesn't recover to 1.3% by Q4, credibility collapses. This is the number to watch.
Retail franchise delay: 6-year stagnation, now FY28 launch
HighThe core strategy (SBS 2030) hinges on retail deposit and asset scaling. If FY28 launch slips again, the entire margin-recovery thesis falls apart. Analysts (Vibhor Talreja, Nest Amplifier) explicitly challenged 6-year visibility gap.
Asset quality volatility in SME/BLG: slippages ₹98 Cr Q1, ₹200 Cr Q3, ₹60 Cr Q4
MediumSmall portfolio magnifies volatility; raised credit bar due to macro/tariff uncertainty. Recoveries promised Q2–Q3 but timing uncertain. If slippages persist or migrate to other segments, NNPA will spike.
Gold regulation tightening: end-use monitoring, RBI guidance on repledger, LTV risk
Medium54% of portfolio; yield 11.85%; agri gold at 85% LTV (Board guidance to reduce). If regulation tightens further (e.g., LTV caps, yield restrictions), growth and profitability are at risk.
Treasury and other income remain suppressed: down 7% YoY, treasury gains 94% lower
MediumManagement describes as 'conservative,' held AFS book. If interest rates fall further, MTM losses possible. If rates spike, other income likely remains constrained by risk management.
FII outflows accelerating: down 132 bp in last quarter, market cap down 42.5%
MediumInstitutional re-rating lower due to guidance misses and execution uncertainty. Further outflows could exacerbate drawdown and reduce analyst coverage.
Wholesale franchise ROA/RAROC not yet proven: growing 35–40% YoY, costs high, transaction banking immature
LowWholesale is 26% of portfolio, slated to grow to 32% by FY30. If unit economics don't improve (RAROC, fee income from transaction banking), the shift from gold-centric to balanced will dilute profitability rather than improve it.
What to watch next
1 · Q2 NIM and deposit mix signals
Will bulk repricing accelerate (cost of funds moving up)? Will retail deposits start accumulating toward FY28 ramp? If NIM recovers even 2–3 bp QoQ, management credibility rebounds; if it stays flat or compresses, the deposit-cost-pressure narrative hardens.
2 · ROA trajectory through H1 FY27
Management promised Q1 was 'worst case' and recovery 'same pattern as last year.' Track quarterly ROA: does it move toward 1.3% floor by Q2–Q3? Failure to reach 1.3% by Q3 would invalidate guidance and force downside revision.
3 · Retail franchise launch credentials (FY28)
By Q4 FY27, management should detail CASA/savings product specs, sales team hiring, branch readiness, and customer acquisition roadmap. Vagueness or further delay signals execution risk and extends the margin-compression window.
4 · Asset quality recovery in SME/BLG
Are the ₹98 Cr Q1 slippages upgraded in Q2–Q3 as promised? If slippages re-emerge or accelerate, it signals macro headwind (tariffs, supply-chain disruption) persistence and justifies raised credit bar.
5 · Analyst rerating and FII flow reversal
Does the 42.5% drawdown and FII outflow reverse if management proves NIM/ROA recovery traction? Or do further misses trigger downgrades and deeper cuts?
The honest close
CSB Bank is not a broken company. It has genuine strengths: outpacing industry deposit and advance growth, solid asset quality, a coherent long-term strategy (SBS 2030), and completed technology transformation. But this quarter is a step down, not a step forward. Loan growth, margins, ROA, and ROE all missed guidance. Profitability fell sharply quarter-on-quarter. Deposit cost pressure is structural and persists for 3+ quarters. Retail franchise, the lynch pin of the recovery narrative, is not launching until FY28, and track record over the past 6 years provides little comfort.
The market is pricing this correctly. At 42.5% below all-time high, with FII exiting and the post-result momentum failing to recover, the stock reflects the gap between the headline growth story and the profitability recovery story. Near-term, CSB is a hold at best. The stock will re-rate only when management demonstrates ROA recovery traction (1.3% floor by Q3 FY27), deposit mix beginning to shift (CASA/retail signals), and asset quality stability (no SME slippage re-emergence). Until then, the margin-pressure and execution-risk overhang persists.
The single number to track from here is ROA by Q3 FY27. If it rises to 1.2% or higher, the bear case weakens and the long-term story re-gains traction. If it stays below 1.1%, the guidance-miss pattern extends, and a further downside cut is likely.